Prospect for pharmacological therapies to treat skeletal muscle dysfunction.
about
Psoas muscle volume as a predictor of peripheral neurotoxicity induced by primary chemotherapy in ovarian cancers.Sarcopenia in cases of chronic and acute illness. A mini-review.Does Activin Receptor Blockade by Bimagrumab (BYM338) Pose Detrimental Effects on Bone Healing in a Rat Fibula Osteotomy Model?
P2860
Prospect for pharmacological therapies to treat skeletal muscle dysfunction.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Prospect for pharmacological therapies to treat skeletal muscle dysfunction.
@en
type
label
Prospect for pharmacological therapies to treat skeletal muscle dysfunction.
@en
prefLabel
Prospect for pharmacological therapies to treat skeletal muscle dysfunction.
@en
P2860
P1476
Prospect for pharmacological therapies to treat skeletal muscle dysfunction.
@en
P2093
Matthew N Meriggioli
P2860
P2888
P304
P356
10.1007/S00223-014-9926-8
P407
P577
2014-11-04T00:00:00Z
P6179
1024222093